Aspirin Fails to Boost Survival in Colorectal Cancer Trial

Watchdoq January 16, 2025
(MedPage Today) -- Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly improve disease-free survival (DFS) and overall survival, the phase III randomized ASCOLT study showed...

Read Full Article